Does TACROLIMUS Cause Hemiparesis? 161 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 161 reports of Hemiparesis have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.2% of all adverse event reports for TACROLIMUS.
161
Reports of Hemiparesis with TACROLIMUS
0.2%
of all TACROLIMUS reports
61
Deaths
112
Hospitalizations
How Dangerous Is Hemiparesis From TACROLIMUS?
Of the 161 reports, 61 (37.9%) resulted in death, 112 (69.6%) required hospitalization, and 56 (34.8%) were considered life-threatening.
Is Hemiparesis Listed in the Official Label?
Yes, Hemiparesis is listed as a known adverse reaction in the official FDA drug label for TACROLIMUS.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Hemiparesis?
ASPIRIN (538)
FINGOLIMOD (534)
METHOTREXATE (534)
RIVAROXABAN (363)
PREDNISONE (359)
METFORMIN (353)
DIMETHYL (345)
RITUXIMAB (331)
CLOPIDOGREL BISULFATE (327)
ATORVASTATIN (317)
Which TACROLIMUS Alternatives Have Lower Hemiparesis Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB